Evercore ISI Increases Envista (NYSE:NVST) Price Target to $23.00

Envista (NYSE:NVST - Get Free Report) had its price target raised by investment analysts at Evercore ISI from $19.00 to $23.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has an "outperform" rating on the stock. Evercore ISI's price objective would suggest a potential upside of 11.06% from the company's previous close.

A number of other research analysts also recently weighed in on the company. Piper Sandler dropped their price target on Envista from $18.00 to $17.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 30th. Baird R W raised shares of Envista from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, May 27th. Morgan Stanley set a $16.00 price objective on shares of Envista in a research note on Tuesday, April 15th. UBS Group dropped their price objective on shares of Envista from $21.00 to $18.00 and set a "neutral" rating on the stock in a research note on Monday, May 5th. Finally, Robert W. Baird raised shares of Envista from a "neutral" rating to an "outperform" rating and raised their price objective for the company from $21.00 to $23.00 in a research note on Tuesday, May 27th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $20.23.

Envista Trading Up 1.6%

Shares of NYSE:NVST traded up $0.33 during mid-day trading on Wednesday, hitting $20.71. The company had a trading volume of 2,383,777 shares, compared to its average volume of 2,489,945. The firm has a fifty day moving average price of $18.58 and a 200 day moving average price of $18.51. The company has a market capitalization of $3.51 billion, a PE ratio of -3.17, a price-to-earnings-growth ratio of 1.30 and a beta of 1.00. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.12 and a quick ratio of 1.82. Envista has a one year low of $14.22 and a one year high of $23.00.

Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.24 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $0.04. Envista had a positive return on equity of 4.07% and a negative net margin of 44.90%. The business had revenue of $616.90 million for the quarter, compared to the consensus estimate of $608.17 million. During the same period in the prior year, the business earned $0.26 EPS. The firm's revenue for the quarter was down 1.1% on a year-over-year basis. As a group, research analysts forecast that Envista will post 1 EPS for the current year.

Institutional Trading of Envista

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Alliancebernstein L.P. boosted its holdings in shares of Envista by 1,985.1% during the first quarter. Alliancebernstein L.P. now owns 4,550,789 shares of the company's stock worth $78,547,000 after purchasing an additional 4,332,541 shares during the period. Franklin Resources Inc. boosted its holdings in shares of Envista by 72.6% during the fourth quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company's stock worth $132,223,000 after purchasing an additional 2,882,844 shares during the period. Brickwood Asset Management LLP purchased a new stake in shares of Envista during the fourth quarter worth about $40,037,000. Norges Bank bought a new stake in Envista in the fourth quarter valued at $38,052,000. Finally, Dimensional Fund Advisors LP boosted its holdings in Envista by 24.0% in the first quarter. Dimensional Fund Advisors LP now owns 8,387,297 shares of the company's stock valued at $144,760,000 after acquiring an additional 1,625,206 shares in the last quarter.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.